RT Journal Article
SR Electronic
A1 Nierengarten, Mary Beth
T1 Early Data Show Safety and Efficacy of SAPIEN Pulmonic THV
JF MD Conference Express
YR 2014
FD SAGE Publications
VO 14
IS 13
SP 17
OP 18
DO 10.1177/155989771413009
UL http://mdc.sagepub.com/content/14/13/17.abstract
AB Early data on the use of the Edwards SAPIEN transcatheter heart valve (THV) for use in the pulmonary position to treat patients with pulmonic disease show excellent clinical outcomes, as well as the durability of the device without stent fractures or the development of endocarditis. This is according to the results of the first 50 patients enrolled in the Congenital Multicenter Trial of Pulmonic Valve Regurgitation Studying the SAPIEN Interventional THV trial [COMPASSION; NCT00676689].